BESSY II@HZB offers the experimental infrastructure for a research community encompassing a wide spectrum of fields. There are many people working in the background to ensure all instruments are in optimal condition for their experiments. This includes around 80 beamline scientists, some of whom we have already introduced. Here in our blog, they talk about their work collectively under #BESSYBeamlineScientists
BESSY II – behind the scenes
From MIT to Wannsee
For Marcel Risch, it feels like a homecoming: as a student, he had previously run experiments at the Berlin particle accelerator BESSY II. After working for several years at Massachusetts Institute of Technology (MIT) and then in Göttingen, he is now establishing his own group at HZB – supported by funding from the European Research Council.
Achieving climate targets with building integrated photovoltaics
In cities with multi-storey construction, roof areas are not sufficient to cover the electricity demand with photovoltaics. Active facade elements make additional areas usable. So far, however, such building-integrated PV modules have rarely been installed. The Advisory Centre for Building Integrated Photovoltaics (BAIP) at the HZB wants to change this. Blog post building integrated photovoltaics
Using BESSY II in the fight against plastic waste
Many people buy drinks in PET plastic bottles. Unfortunately, it has never been possible to fully recycle this plastic. In 2016, researchers in Japan have discovered bacteria that can break down PET into its basic components. By experimenting at BESSY II, a team from Universität Greifswald and HZB recently deciphered one of the two most crucial enzymes in this process. Their work points the way towards perfect recycling of PET plastics.
BER II Decommissioning
The Berlin experimental reactor BER II will be finally shut down at the end of 2019. We are currently preparing the decommissioning of the BER II. (in German)
Patients with eye tumours are being treated with proton beams since June 1998 by the Charité Universitätsklinikum Benjamin Franklin together with the Helmholtz-Zentrum Berlin. Especially, we succeed to destroy the tumour in more than 97 percent of the patients. Eye tumour therapy with protons